Lynda Stranix‐Chibanda

机构：University of Zimbabwe · ORCID：0000-0003-3566-1688

发表论文 125 篇 · 总被引 2440 次 · h-index 25

代表论文

• Safety, tolerability, and acceptability of long-acting injectable cabotegravir for HIV prevention in cisgender female adolescents (HPTN 084-01): a single-arm, open-label, phase 2b trial (2025 · The Lancet HIV · 被引 10)
• Cost-effectiveness of broadly neutralizing antibodies for HIV prophylaxis for infants born in settings with high HIV burdens (2025 · PLoS ONE · 被引 7)
• Bone Mineral Content, Growth, and Renal Health of Infants With Perinatal Exposure to Maternal Dolutegravir Versus Efavirenz and Tenofovir Disoproxil Fumarate Versus Tenofovir Alafenamide: The Randomized IMPAACT 2010 (VESTED) Trial (2025 · JAIDS Journal of Acquired Immune Deficiency Syndromes · 被引 4)
• Bone mineral density changes in breastfeeding women with HIV on antiretroviral therapy in Eastern and Southern Africa (2025 · AIDS · 被引 4)
• Hepatotoxicity Among People With HIV and Receiving Isoniazid Preventive Therapy in Pregnancy and Postpartum: The Role of Antiretroviral Regimen and Pharmacogenetics (2025 · Clinical Infectious Diseases · 被引 3)
• Pharmacokinetic interaction assessment of an HIV broadly neutralizing monoclonal antibody VRC07-523LS: a cross-protocol analysis of three phase 1 trials in people without HIV (2025 · BMC Immunology · 被引 3)